OpenBilldrug price receipt

NADAC week of 2026-10-14

XELSTRYM 9 MG/9 HR PATCH

FDA nonproprietary name: dextroamphetamine

For 1 patch

Pharmacies pay

$16.26 filed

1 × $16.2602 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$15.86 filed

1 × $15.86112 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.98× estimated

Medicare paid about what pharmacies pay.

Part D averages every strength and form sold under “Xelstrym” / “Dextroamphetamine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$23.70 estimated

$16.26 + $2.44 (15%) + $5.00 fee per fill = $23.70

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

XELSTRYM 9 MG/9 HR PATCH is how the CMS NADAC file names this product. The FDA NDC Directory lists it as dextroamphetamine, under the trade name “XELSTRYM”.

FDA gives its dosage form as patch, extended release and its route as transdermal.

The labeler, the company named on the label, is Noven Therapeutics, LLC.

FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes); the FDA directory lists 1 of them.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $16.26 for 1 patch (1 × $16.2602 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 2 NDCs

Other strengths, forms and brands

4 other products in the NADAC file share the FDA nonproprietary name dextroamphetamine with XELSTRYM 9 MG/9 HR PATCH.

ProductPharmacies pay per unitMedicare per unit
DEXTROAMPHETAMINE 5 MG/5 ML
generic · solution
$1.14342 per ML filed
eff. 2026-09-23
We don’t know yet
XELSTRYM 4.5 MG/9 HR PATCH
brand · patch, extended release
$16.22856 per EA filed
eff. 2026-09-23
$15.86112 per EA filed
Part D 2024 average
XELSTRYM 9 MG/9 HR PATCH this page
brand · patch, extended release
$16.2602 per EA filed
eff. 2026-09-23
$15.86112 per EA filed
Part D 2024 average
XELSTRYM 13.5 MG/9 HR PATCH
brand · patch, extended release
$16.25846 per EA filed
eff. 2026-09-23
$15.86112 per EA filed
Part D 2024 average
XELSTRYM 18 MG/9 HR PATCH
brand · patch, extended release
$16.22681 per EA filed
eff. 2026-09-23
$15.86112 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $16.2602 per EA filed.

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 14 have a higher middle NADAC price and 189 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $15.86 for 1 patch, at an average of $15.86112 per EA in 2024 (2024-01-01 to 2024-12-31) for “Xelstrym” and “Dextroamphetamine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 417 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for XELSTRYM 9 MG/9 HR PATCH labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Xelstrym / Dextroamphetamine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
Why does this page start at 1 patch?
NADAC prices this product per EA, and the FDA NDC Directory lists 1 of its 2 NDCs (it does not list the other one) as dosage form “PATCH, EXTENDED RELEASE” with route “TRANSDERMAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and this is not one. So the card starts at 1 patch, priced per patch, rather than guess how many make up a fill; change it to match your prescription.